Reciprocal Effects of STAT5 and STAT3 in Breast Cancer
Open Access
- 23 June 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 7 (6), 966-976
- https://doi.org/10.1158/1541-7786.mcr-08-0238
Abstract
Breast cancer is often associated with inappropriate activation of transcription factors involved in normal mammary development. Two related transcription factors, signal transducer and activator of transcription (STAT) 5 and STAT3, play important and distinct roles in mammary development and both can be activated in breast cancer. However, the relative contribution of these STATs to mammary tumorigenesis is unknown. We have found that primary human breast tumors displaying activation of both STATs are more differentiated than those with STAT3 activation alone and display more favorable prognostic characteristics. To understand this difference, we have analyzed the effect of these STATs on gene regulation and phenotype of mammary carcinoma cells. STAT5 and STAT3 mediate opposing effects on several key target genes, with STAT5 exerting a dominant role. Using a model system of paired breast cancer cell lines, we found that coactivation of STAT5 and STAT3 leads to decreased proliferation and increased sensitivity to the chemotherapeutic drugs paclitaxel and vinorelbine compared with cells that have only STAT3 activation. Thus, STAT5 can modify the effects of STAT3 from the level of gene expression to cellular phenotype and analysis of the activation state of both STAT5 and STAT3 may provide important diagnostic and prognostic information in breast cancer. (Mol Cancer Res 2009;7(6):966–76)Keywords
Other Versions
This publication has 50 references indexed in Scilit:
- Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3Blood, 2008
- Predicting features of breast cancer with gene expression patternsBreast Cancer Research and Treatment, 2007
- STAT3 as a central mediator of neoplastic cellular transformationCancer Letters, 2006
- STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomasOncogene, 2006
- BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphomaBlood, 2006
- X chromosomal abnormalities in basal-like human breast cancerCancer Cell, 2006
- Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer CellsClinical Cancer Research, 2006
- Evaluation of potential Stat3-regulated genes in human breast cancerBiochemical and Biophysical Research Communications, 2005
- BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profilesBreast Cancer Research and Treatment, 2005
- Deregulation of Stat5 expression and activation causes mammary tumors in transgenic miceInternational Journal of Cancer, 2004